ACTRN12622000977774
Completed
未知
An open-label, uncontrolled acceptability trial of a therapist-assisted, online parenting program (‘PiP-Education’) to support parents of adolescents who refuse school in the context of anxiety and/or depression.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Monash University
- Enrollment
- 14
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Group 1: Parents and/or guardians of adolescents aged 12\-18 years who:
- •\- are refusing school due to anxiety and/or depression
- •\- live in Australia
- •\- are proficient in English
- •\- have regular internet access
Exclusion Criteria
- •Group 1: Parents
- •1\. Parents of an adolescent who experienced first onset of school refusal prior to the current school year (2022\).
- •2\. Parents of an adolescent who experiences a physical illness that precludes their school
- •attendance, or are refusing school for any reason other than due to anxiety/depression related to attendance.
- •3\. Parents of an adolescent who has a principal mental health condition that is of sufficient severity to require immediate clinical prioritisation (e.g. suicidality, current alcohol/substance dependence, acute mental health crisis)
- •4\. Parents of an adolescent who has Autism Spectrum Disorder (ASD) or an intellectual disability.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluating the acceptability of a self-guided online parenting program (‘PiP-Ed’) to support parents of adolescents who refuse school in the context of anxiety and/or depressioParental self-efficacyAdolescent school refusalPublic Health - Health promotion/educationMental Health - AnxietyMental Health - DepressionACTRN12622001365752Monash University200
Active, not recruiting
Phase 1
Study to evaluate the tolerability of a combination therapy consisting of GAD-alum (Diamyd®), etanercept and vitamin D in children and adolescents newly diagnosed with type 1 diabetesewly diagnosed Type 1 diabetes (within 100 days)MedDRA version: 17.1 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2014-001323-76-SEinköping University20
Not yet recruiting
Not Applicable
Evaluating uptake, engagement and effects of the Partners in Parenting (PiP) online parenting program, for adult carers of adolescents (12-18), delivered via headspace National Youth Mental Health Foundation.ACTRN12623000642684Monash University500
Completed
Not Applicable
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C and compensated cirrhosis patients with the prescribing pattern of vitaminD plus peginterferon alpha-2a /ribavirin.Chronic hepatitisC patients and compensated cirrhosis patientsJPRN-UMIN000008342Saitama Medical University80
Completed
Not Applicable
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C patients with vitaminD plus peginterferon alpha-2a /ribavirin.versus alfacalcidol plus peginterferon alpha-2a /ribavirin.Chronic hepatitis C patients with genotype 1 and high viral load (>= 5 Log IU/mL)JPRN-UMIN000004210Saitama Medical University40